Thursday, May 14, 2026
Home Blog Page 431

Grief During The Holidays Is Common — Here’s How To Cope

0

The holidays are a nostalgic and celebratory time of year, making it difficult to grieve properly. Here are some tips that can help you cope.

This time of the year is meant to be cheerful and celebratory, but in reality, for many, the holidays are often experienced with a tint of loss. While many feel happy over holiday decorations, rituals and time spent among family, others experience sadness and mixed feelings over the passage of time and the reminder of missed opportunities. This year is particularly difficult, with no way to avoid loss on a personal and global level.

Directly or indirectly, we’ve all been affected by COVID-19. It’s a difficult topic to escape, one that has taken almost 2 million lives worldwide. For those experiencing grief over the loss of a family member due to COVID-19, it’s virtually impossible to escape grief during the holiday season.

While there’s no shortcut for grieving, there are ways of making these experiences healthier and more manageable. Here are a few tips that can help you cope with grief during the holiday season:

Try your best to let go of expectations

How To Make This Year's Holidays Special
Photo by Eugene Zhyvchik via Unsplash

The holiday season is tied to a lot of expectations, whether they’re related to the food you’ll be eating, the amount of drinking you’ll be doing or the company you keep. Rising cases of COVID-19 have thrown all planning out the window, with many choosing to spend the holidays alone in order to keep their family safe.

There’s no need to maintain a celebratory mood, even when going through the holidays or meeting up with others. It’s been a difficult year and you should give yourself permission to not celebrate if you don’t want to. If you feel happy and joyful, it’s also important to avoid punishing yourself over your feelings.

Plan, plan, plan

5 Things That’ll Help You Schedule Sex Without Killing Romance
Photo by rawpixel.com

While you may choose to not do anything this holiday season, having a plan might help you stay busy. Planning ahead of time helps people face adversity better, making them feel more prepared and purposeful. Making plans with friends or loved ones is also especial during the holiday season; while you may have lost someone, there are still people who love you and want to spend time with you.

RELATED: 5 Ways To Take Care Of Your Mental Health During The Holidays

Still, if the holidays remind you too much of someone and you fear reminiscing, it’s okay. Talk it out with your friends and family and let them know that while you still love them, you’d prefer to avoid celebrations of any sort. Reach a compromise over ways of connecting and staying in touch while also giving you the necessary space to grieve.

Be compassionate with yourself

Spending The Holidays Alone? Here's How To Make The Most Of It
Photo by Anthony Tran via Unsplash

RELATED: A Gift Guide For Someone Who’s Had A Rough Year

There’s no “right way” to grieve, which can be disorienting and frustrating. The grieving process changes from person to person, with some experiencing marked sadness and others taking more time to untangle their feelings. If you feel happy and are smiling throughout the season, it’s okay. It’s also okay if you’re experiencing the opposite. Allow yourself to feel your feelings and to learn how your grieving process works as you go through with it.

What’s In A Name? Forget The Strain Name

Don’t be fooled by strain names. That cannabis you just bought might be totally different than the last time you smoked it.

Editors Note: This is part two of a three-part series. You can read part one here.

Blue Dream, Purple Haze, Girl Scout Cookies, Red Headed Stranger, Acapulco Gold, Fruity Pebbles or Pineapple Express… all classic strain names and all of them meaningless.

“Strain names are absolutely misleading with considerable variation in the same cannabinoid content among different specimens of the same strain. You can get the same color and the same smell, but actually levels of the THC and CBD and some of the other compounds could be quite different,” says Robin Marles, Ph.D., chair of the U.S. Pharmacopeia (USP) Botanical Dietary Supplements and Herbal Medicines Expert Committee.

USP has assembled an expert panel of clinicians, scientists and industry representatives from around the world to provide necessary information and guidance on critical quality attributes, including recommendations for naming , all laid out in an article in the Journal of Natural ProductsCannabis Inflorescence for Medical Purposes: USP Considerations for Quality Attributes.

“USP recommendations are entirely focused on the inflorescence of the cannabis plant, popularly known as the flower or ‘the bud.’ And as with any plant product, the first challenge was to determine how to classify the various varieties and subtypes that are currently in use.” said Ikhlas Khan, Ph.D., USP’s Cannabis Expert Panel chair.

USP has elected to recognize cannabis as a single plant species, Cannabis sativa L., with different varieties or subtypes that can then be classified based on their THC and CBD content. The expert panel provided guidance for organizing the plant material into three “chemotype” categories: THC-dominant, CBD-dominant, or intermediate varieties that contain physiologically meaningful levels of both – intending to give prescribers or consumers greater clarity about what substances they are using.

Why you didn't get the cannabis strain you think you did
Photo by Zummolo/Getty Images

In order to properly identify and quantify these cannabis varieties, USP’s expert panel recommended the use of science-based analytical procedures for the industry to employ.  This entails the use of high-performance liquid chromatography (HPLC) and gas chromatography (GC) to separate and quantify not just THC and CBD, but also 11 other cannabinoids that are less studied, but may also have an impact on the effect of cannabis products.

RELATED: Why You Didn’t Get The Cannabis Strain You Think You Did

USP  has also looked at the composition of terpenes, which are largely responsible for the flavor and odor of cannabis. They identified five different terpenes that are especially abundant in cannabis that could also help with classification: myrcene, limonene, terpinolene, pinene and caryophyllene. Terpenes may form the basis for further subcategorization of cannabis chemotypes to establish the impact of these substances on the pharmacological effects of cannabis products when used in clinical practice.

RELATED: The USP Lays Out Guidelines For Medical Cannabis

“Naming cannabis varieties based on detailed profiles of cannabinoid and terpene content can also help guide prescribers and help ensure that patients are consistently receiving the cannabis varieties that they intended,” said Nandu Sarma, Director, Dietary Supplements and Herbal Medicines at USP.

This article originally appeared on Green Market Report and has been reposted with permission.

Cannabis Gifts Becoming The Hottest 2020 Trend

The number one reason for cannabis consumption given was to get a better night’s sleep, followed by “general wellness” with “just for fun” coming in third.

The Post Office is backed up, mall Santas far and wide are doling out Christmas cheer from inside plastic bubbles, and the conundrum of what to gift someone who has quite likely been through one of the hardest years of their life (spoiler: that’s almost all of us) are making holiday shopping a real conundrum this year.

According to a new consumer poll conducted by vertically integrated cannabis and hemp company Glass House Group, a significant number of customers will be rising to the Covid Christmas challenge by giving the gift of cannabis.

With more than 630 respondents citing floweredibles, and pre-rolls as top choices for their holiday gifts, results suggest that cannabis gifting is among Christmas 2020’s hottest consumer trends. This points to the mainstreaming of cannabis as well as other factors. A majority of poll respondents (64.2%) stated that they plan to reduce alcohol consumption with cannabis during the holidays, with 67.4% predicting that they will replace alcohol with cannabis to a greater extent than they did in 2019.

The heightened focus on health and wellness concerns prompted by the pandemic is also a contributing factor, not just through attempts to reduce alcohol consumption but to manage holiday stress (53.4% of respondents) and relieve pain (50.3%).  The number one reason for cannabis consumption given was to get a better night’s sleep, followed by “general wellness” with “just for fun” coming in third.

A Gift Guide For Someone Who's Had A Rough Year
Photo by Kira auf der Heide via Unsplash

So with all of this wellness-minded gifting (71.2% of respondents plan to give cannabis to friends, with family coming in second at 65.2%), what might one find under the tree or peeking out of a stocking this year? Glass House’s poll shows flower topping the list, with 65.8% of respondents planning to buy buds for their buds, while edibles, pre-rolls, and CBD products ranked second, third, and fourth respectively. Flower also received top designation as the form of cannabis consumers are hoping to receive this year.

RELATED: Cannabis For The Holiday Hangovers

This bodes well for a merry Christmas morning among the discarded wrapping paper and ribbon. The rest of cannabis products follow a similar order of preference to those most likely to be given with the exception of vapes, which ranked above CBD products as the gift 33.2% of respondents hope to receive.

RELATED: Cannabis Industry Insiders Look Ahead To 2021

Glass House Group Co-Founder, Chairman, and CEO Kyle Kazan believes that this poll reflects a paradigm shift towards cannabis as a mainstream choice for consumers. “As we make our way into 2021, we will look forward to rolling out new products from Glass House Farms, bringing our customers new retail experiences and continuing to provide new insights into the fastest-growing consumer movement our country has seen in nearly a century.”

This article originally appeared on Green Market Report and has been reposted with permission.

5 Ways To Take Care Of Your Mental Health During The Holidays

0

Before you give to friends and family this year, make sure to prioritize your mental well-being.

Mental health has been an increasing topic of concern for Americans, with adults reporting worsening stats each year. This year, with the pandemic, mental health experts are questioning the repercussions of the experiences we are living through and how these will shape our future.

The holidays are usually an anxiety inducing time anyway, but this year, many of us will spend our time alone, creating a perfect scenario for a mental health crisis. Here are 5 things you can do in order to keep your mental health in check:

Find some purpose

When faced with stress and lots of free time, it’s important to try to give some structure to your day. When depressed and alone, it’s easy to spend all day lying in bed, doing nothing. Sometimes this is an inevitability and it’s okay to give your body and mind the time it needs to process and heal. But if you can feel the onset early on, you can try to curb it by planning some activities ahead of time. Aside from making sure you’re eating healthy and getting enough exercise, volunteering is a good activity to commit to, to whatever degree you feel comfortable with. Look for causes to donate money, clothes or food to, or figure out resources that can connect you to sponsoring a family.

Make time for self care

5 CBD Products For When You Need To Relax
Photo by cottonbro via Pexels

RELATED: A Gift Guide For Someone Who’s Had A Rough Year

Self-care is a word that gets thrown around a lot nowadays, referring to multiple things: It can mean having a luxurious bath or preparing some pop corn and watching a movie. Make sure that you spend this time purposefully, hopefully de-stressing a bit and finding ways to enjoy yourself when you need it most.

Plan for the coming year

Planning is effective in helping us not only feel prepared, but purposeful. While it’s difficult to plan with a pandemic that limits outings and meetups with friends, the end of the year is a significant moment. You can use the occasion to visualize plans for 2021, including things you want to improve on.

Check in with loved ones

Ask Mister Manners, Thomas P. Farley: 'Do I Give A Gift If It’s A Virtual Wedding?'
Photo by Edward Jenner via Pexels

RELATED: 5 Everyday Places Where COVID-19 Is Spreading

While you may want to hide away from your loved ones during times of stress, most people are going through the same stuff, feeling sad and isolated. Try reaching out to your friends and family, checking in on how they feel. If the festivities are important for you and your family, plan a Zoom event, preferably with some drinking and food involved since that makes the gatherings flow easier and gives your meeting a sense of purpose.

Ask for help if you need it

If you’re feeling very isolated and depressed, reach out to a friend or a professional who can guide you through this time. Thanks to the pandemic and technological developments, there are many options for remote therapy and mental wellness. Incorporate different wellness practices during this period of time, getting as much help as you can. For starters, here are 5 Tips To Make The Most Of Your Online Therapy Sessions.

USP Lays Out Guidelines For Medical Marijuana

The organization’s goal in this area is to provide suitable methods and reference standards that can help the industry and regulators ensure cannabis quality

Editors Note: This is part one of a three-part series of articles.

Good, news  U.S. Pharmacopeia (USP) lays out guidelines for medical marijuana.  The organization is bringing cannabis back into cannabis into the fold and has provided guidelines for labs and cultivators around the globe to utilize to help provide consumers with quality cannabis products.

“There is a critical and growing need for the scientific articulation of quality attributes for cannabis and related products to help protect patients and consumers from harm. As more products become available and sourced more broadly, and states continue to adopt initiatives allowing the use of cannabis for medical purposes, potential exposure to and associated risk of harm from contaminated, substandard, or super potent products is increasing and we must do what we can to mitigate that risk,” said Jaap Venema, Ph.D., Chief Science Officer at USP.

The organization’s goal in this area is to provide suitable methods and reference standards that can help the industry and regulators ensure cannabis quality, laid out in an article in the Journal of Natural ProductsCannabis Inflorescence for Medical Purposes: USP Considerations for Quality Attributes. Nomenclature is at the top of USP’s “to-do list,” an important quality attribute for labeling the ingredients, to help patients and healthcare professionals assess whether a product is suitable for particular needs.

“The thousands of so-called ‘strains’ are not consistent in either morphological or chemical profiles and cannot be relied upon for consistent categorization of different kinds of cannabis. Identity of cannabis and cannabis-derived products should be linked with clear nomenclature, including reference to plant part, product, and/or herbal preparation,” said Robin Marles, Ph.D., chair of the USP Botanical Dietary Supplements and Herbal Medicines Expert Committee.

FDA Guidance On Cannabis Research- A Glimpse Of What’s To Come For CBD Products?
Photo by Larisa Shpineva/EyeEm/Getty Images

USP has elected to recognize cannabis as a single plant species, Cannabis sativa L., with different varieties or subtypes that can be classified based on their THC and CBD content. The guidelines in the Journal of Natural Products article organize the plant into three ‘chemotype’ categories: THC-dominant, CBD-dominant, or intermediate varieties that contain physiologically meaningful levels of cannabinoids.

RELATED: Why You Didn’t Get The Cannabis Strain You Think You Did

USP is an independent, scientific, nonprofit public health organization devoted to improving health through the development of public standards for the quality, safety, and benefit of medicines and foods. The organization is comprised of over 450 academic institutions, healthcare practitioner organizations, industry groups and government representatives. USP standards are enforced by the FDA in the U.S., but since cannabis is still generally illegal under federal law, USP has not created formal compendial standards at this time. They have published a scientific paper instead of creating a conventional USP monograph. However, they still employed their rigorous process for creating the guidelines.

RELATED: Here’s Why You Have To Trust Your Dispensary

“This document is just a first step. Much remains to be learned about the clinical utility of this plant and it’s likely that future research will generate greater complexities in classification as we gain a greater understanding of its physiological effects,” said Ikhlas Khan, Ph.D., USP Cannabis Expert Panel chair.

The guidelines in the article also recommend best practices for sampling, strength and composition, and contaminant identification and limits. The hope is that they outline core quality attributes and tools that may serve as resources for quality control of the plant.

This article originally appeared on Green Market Report and has been reposted with permission.

How To Make The Holidays Feel Less Lonely This Year

0

This December marks the end of a year unlike any other in recent memory. Here’s how you can make it feel special if you’re celebrating solo.

This holiday season will be a bit unconventional, with most of us having limited options for entertaining ourselves or meeting up with friends and family. While some people have bubbled up with others, the majority of us will likely limit our social group for the season, foregoing visiting parents and grandparents in order to avoid exposing them to the unnecessary risk of COVID-19.

While this is the right thing to do, it makes for a stressful and sad holiday season, one that will be difficult to cope with for many. Here are a few simple things you can do to make the holidays feel special during the pandemic:

Fill your calendar

Photo by Flickr user Tina D

This year has been rough on relationships of all kinds. The pandemic has made it difficult for us to see each other, and when talking or texting, it leaves us in an awkward position of not having much to say. Yes, we spend most of your day indoors. There’s nothing new to discuss.

Use the holidays as an opportunity to reconnect, scheduling phone calls, Zoom chats or distanced hangouts with those that live close to you. If you haven’t talked to a friend much throughout the year, or have disagreed with their approach to the pandemic, use this time to reach out and overcome your differences.

Foster an animal

Photo by Andy Omvik via Unsplash

Animals make great companions and cuddle buddies, especially when you’re feeling lonely or sad. If you want temporary company, volunteer for walks at animal centers or ask a friend to pet sit one of their pets. If you want something for a longer period of time, look into fostering animals.

Cook something special for someone

Photo by Erol Ahmed via Unsplash

RELATED: Spending The Holidays Alone? Here’s How To Make The Most Of It

Cooking is a great distraction, one that’s soothing and time consuming, perfect for lonely holidays. What’s not great is cooking for one, which involves a lot of work and very brief enjoyment. The next time you want to cook, prepare bigger portions and give them to loved ones who live close to you. They’ll appreciate the gesture and you can use this opportunity to hang out with someone new.

Allow yourself to feel sad

5 Signs You Might Have Seasonal Depression
Photo by Dmitry Schemelev via Unsplash

RELATED: 5 Everyday Places Where COVID-19 Is Spreading

Perhaps the best thing you can do this month is to allow yourself to feel all of your emotions, happy and sad alike. The holidays are always complex, whether you spend them alone or with family. This year has been tough, and the end of it will likely result in a cathartic moment. Give yourself the room to feel it all, to reach out for help, and to get ready for the coming year. You’ll feel better.

Alternative Plant Medicine, Cannabis And Pain Management

As time goes on, alternative plant medicine, such as cannabis, are slowly changing the way pain management is viewed and executed.

Did you know that in 2019, chronic pain impacted one-third of the U.S. population? This number continues to rise which has lead to a variety of treatments tried by sufferers.  One that is gaining traction? The alternative plant medicine, cannabis and pain management.

Currently, different NSAIDs (non-steroidal anti-inflammatory drugs), acetaminophen, and opioids are used the most often for the treatment of pain. However, there’s no guarantee that these drugs will be fully effective in eliminating pain nor is there a guarantee that these drugs won’t cause any adverse side effects.

Nowadays, cannabis and its many cannabinoids are being pursued more because of their medicinal and therapeutic properties.Overall, though, alternative plant medicine is becoming a part of thousands of people’s routines and lifestyles for numerous reasons. Here are a few main reasons why.

Understanding Types of Pain and How to Treat It Properly

Oftentimes, when someone experiences pain, their primary mission is to eliminate it and use or consume a product to achieve relief. Before treating pain though, it’s important to understand the characteristics of the pain itself, the severity of it, and the nature of it. For example, is the pain acute or chronic? Is it neuropathic or inflammatory pain? Is the pain caused by an injury, illness, ailment, or a new medication? After understanding the type of pain, finding an appropriate treatment method is the next step.

RELATED: What We Can Learn About Cannabis From Chinese Medicine

When evaluating numerous treatment methods, it’s essential to understand the efficacies of different treatment options and potential adverse effects/reactions. From here, an individual should be able to find a suitable treatment method that aligns with the type of pain they’re experiencing.

Traditional Medicines Versus Alternative Plant Medicines

Although opioids, NSAIDs, acetaminophen, and various OTC (over-the-counter) drugs tend to be the norm for pain management and/or relief, cannabis and its array of beneficial cannabinoids are growing in demand and usage.

Specifically, to avoid potential adverse side effects and/or the risk of drug addiction or dependency, for many, opioids are taking a back seat, and cannabinoids are being pursued instead. Despite traditional medicines demonstrating their efficacy in many different situations and among different people, issues can still arise post-consumption.

RELATED: More Women Switch Out Pharmaceuticals For Medical Marijuana

For example, NSAIDs can be beneficial, but they’ve also been associated with severe complications involving the gastrointestinal, cardiovascular, and renal systems. Next are opioids, which have proven their effectiveness in different situations, but they’ve also demonstrated their ability to cause cognitive deficiencies, motor impairment, and respiratory depression. Opioids also unfortunately represent a substantial addiction and dependency risk among specific groups of individuals.

As time goes on, alternative plant medicine, such as cannabis, numerous cannabinoids, and terpenes, are slowly changing the way pain management is viewed and/or executed.

Israeli Firm Says Medical Marijuana Best Taken In Microdosing Format
Photo by Esther Kelleter/EyeEm/Getty Images

Cannabis For Pain Management & Treatment

The cannabis plant contains over 100 cannabinoids, but some of them are more well-known such as Cannabidiol (CBD) and Tetrahydrocannabinol (THC). Numerous cannabinoids are medically and therapeutically beneficial in multiple ways, but CBD, THC, Cannabichromene (CBC), and Cannabigerol’s (CBG) analgesic properties stand out. So far, it has been found that CBC contains both anti-inflammatory and analgesic properties. Whereas, CBG has proven its stronger analgesic activity than THC. 

Aside from different cannabinoids’ analgesic properties, various terpenes found on the cannabis plant are analgesics as well, especially myrcene. One 2008 study expanded on this and stated that: “Myrcene is analgesic, and such activity, in contrast to cannabinoids, is blocked by naloxone suggesting an opioid-like mechanism.” Another terpene that contains analgesic and anti-inflammatory attributes is β-caryophyllene.

RELATED: Why Cannabis Is Better Than Opioids

In addition, cannabinoid analgesics have generally been well-tolerated within clinical trials. The World Health Organization (WHO) also reported that CBD is non-psychoactive, non-toxic, non-addictive, and has a good safety profile.

Although there’s more to learn about cannabinoids and pain management, various surveys of cannabis users have shed light on the substitution of cannabis products for opioids. Specifically, one 2017 survey focused on American and Canadian cannabis users, and the following was reported: “Our findings are consistent with prior surveys of American and Canadian marijuana users in which substitution of marijuana for opioids was prevalent due to better symptom management and fewer adverse and withdrawal effects.”  

How To Do Your Part In Advancing Cannabis Reform In Your State

0

With much to fight for, marijuana advocates say that people can and should do their part however possible. Here’s how.

Cannabis reform continues to make progress in America. With several states passing legislation on Election Day, and several more on the verge of doing the same soon, some may think that the fight is winding down. That isn’t the case when talking to those involved in the movement.

While much of the decades-long heavy lifting to earn back the public’s support for cannabis is already complete, there is much more to get done. Be it legalization or other policy reforms, advocates across the U.S. can and should still get involved in the fight. Even the most progressive of states continue to suffer pain points that advocates hope to address in a bid to create a fair and equal market for patients, consumers, marginalized communities and everyone else in the space. 

Jordan Isenstadt is the senior vice president of New York-based PR firm Marino. Isenstadt, who has worked in the administration of several New York State Senators and the Governor, spoke about the importance of advocacy in the community. He calls cannabis reform “one of the great social challenges of our time.” 

Isenstadt described the previous century of cannabis policy as failed and racist. “Being an advocate for cannabis today is about righting the wrongs of a century of failed policymaking,” said Isenstadt. He added, “Cannabis advocates have an opportunity to make history over the next few years.”

Wanda James, a career advocate and entrepreneur in and out of cannabis, said that advocacy remains essential because the goal has not been reached–particularly inclusion efforts.

James, CEO of Simply Pure Dispensary and president of the Cannabis Global Initiative, points to the ongoing racial disparity that spans American life, affecting Black and other minority groups at staggering rates. “The only way that we’re going to change how people talk about cannabis is when we fully legalize it,” added James. 

Sources say that advocates are needed in other areas as well, including patient rights. Marijuana Policy Project Director of Government Relations Chris Lindsey noted that medical patients often face steeper challenges as states legalize adult use. 

Lindsey elaborated, saying that advocates help keep the moral compass oriented. “With the huge amount of attention legalization gets from many different groups and agencies, the voice for individuals who rely on these programs for access to medicine shouldn’t be drowned out,” said Lindsey. 

With much to fight for, advocates say that people can and should do their part however possible. 

A Dozen Governors Urge Congress To Pass Marijuana STATES Act
Photo by rawpixel.com

How To Get Involved In Cannabis Advocacy—Even If You Don’t Have The Time

Cannabis advocacy can become a large component of someone’s life just as much as it can become a small part of their day. Either way, sources say these efforts can amount to continued progress.

There appears to be no clear-cut first steps a person should take to become an advocate–mostly because anyone can do their part at just about anytime. 

Simply Pure’s James said the first step a person should do is normalize cannabis conversations and use, as long as the person isn’t risking their job in the process. Essentially, work the plant into everyday conversations and continue with daily practices, like swapping out an end-of-night glass of wine with your partner to a joint.

RELATED: How the Georgia Runoffs Could Shape Cannabis Reform

The cannabis leader then recommends contacting local officials as another quick and effective step. James said advocates could leave a message stating their support for specific measures, giving a brief reason why to back their claim. 

“These conversations and these actions are so simple that we can do,” said James.

Marino’s Isenstadt said education is paramount–suggesting people learn about key stakeholders, regulators, elected officials and other prominent members in the space as a first step.  

A Right-Leaning Supreme Court Won't Impede Cannabis Reform, Legal Experts Say
Photo by Esther Kelleter/Getty Images

From there, would-be advocates can get involved with various advocacy groups. He noted that groups typically consist of various central issues, including pro-business groups that represent large multi-state operators and grassroots advocates for small businesses, farmers, healthcare, social justice and other pressing matters.  

RELATED: A Right-Leaning Supreme Court Won’t Impede Cannabis Reform, Legal Experts Say

“Figure out which organization(s) speaks most to you and look for ways to get engaged,” said Isenstadt. 

James highlighted groups like NORML, Minorities for Medical Marijuana and Women Grow as three organizations advocates should look into. 

RELATED: Why A Biden-Appointed, Pro-Cannabis Attorney General Is Important For Weed Reform 

Isenstadt added that scores of organizations have volunteer and advocacy activities, including virtual events, fundraisers, letter writing and phone to action campaigns. Currently, these events are all virtual. When in-person meetings become the norm again, advocacy events can also help advocates become further ingrained in the fight and the cannabis community by making face-to-face connections.

Isenstadt added that those short on time could make cash donations if they are in the financial position to do so. “It only takes a few minutes to give money, and many of the advocates, especially those fighting for social justice reform, could use the funds.”

Science Confirms Cannabis Combats Cancer

While not sufficient treatment in itself, research continues to find cannabis is an excellent tool in the war against cancer.  

In a recent study, Thomas M. Clark, Ph.D., head of a recent analysis, found that “the anticancer effects of cannabis outweigh the carcinogenic effects even in the airways and bladder, where carcinogen exposure is high.”  This is another example where science confirms cannabis combats cancer.

Clark headed anAugust analysisdirectly on the issue of cannabis and cancer, supported by his sabbatical leave from Indiana University South Bend. At first, Clark had three hypotheses: cannabis increases cancer risk, the benefits and risks of using cannabis canceled out, or cannabis lowers cancer risk. 

At the first analysis of the data set, there was a slight association with cannabis and reduced cancer risk. However, by removing data that did not control for tobacco use, defined as data with a high risk for selection bias, and data at risk for performance bias, the association became medium to large. 

Likewise, the data revealed a medium to large association with reduced cancer risk if data related to testicular cancer was removed. However, according to the analysis, “the hypothesis thatcannabisuse increases cancer risk is not supported by the available data.” 

Making Sense of the Complexity of Cancer Risk 

In the words of Clark, “decreased cancer risk incannabisusers should not be surprising, ascannabisand cannabinoids decrease obesity, inhibit chronic inflammation, reduce fasting insulin levels and insulin sensitivity, and have direct antitumor actions.” 

The Incredible Truth About Marijuana And Bladder Cancer
Photo by Sezeryadigar/Getty Images

The effects cannabis has in fighting obesity are far-reaching and severe. Research on amouse modelfound that not only did THC treatment prevent obesity, but it preserved the gut microbial flora, preventing it from mirroring an obese phenotype. 

RELATED: House Approves Bill To Enhance Medical Marijuana Research

Additionally, cannabis lowers insulin resistance and can act as an anti-inflammatory.Researchhas proven cannabis’s anti-tumor effects in a laboratory setting. 

According to Clark’s math, cannabis may decrease the risk of cancer by 10%. If that is true, then among the 55 million Americans cannabis users, the substance may prevent as many as 23,800 to 35,700 cancer diagnoses and 8,498 to 12,747 cancer deaths each year.  

While not sufficient treatment in itself, research continues to find cannabis is an excellent tool in the war against cancer.  

DEA Hit With Another Lawsuit Scientists About Cannabis

The time is nigh for the DEA to cooperate in ensuring that medical marijuana research can move forward. Finally.

On December 3, 2020, MAPS (the Multidisciplinary Association for Psychedelic Studies) issued a press release regarding a lawsuit filed against the DEA and the Attorney General to “compel issuance of licenses to manufacture marijuana for clinical trials and potential FDA approval.” We have written about MAPS and its 35 years of advocacy and engagement with DEA before, and we are big fans of the nonprofit.

The announcement of this lawsuit comes on the heels of the United Nations Commission for Narcotic Drugs (CND) voting to accept the World Health Organization’s (WHO) recommendation to remove cannabis and cannabis resin for medicinal purposes from Schedule IV of the 1961 Single Convention on Narcotic Drugs. The U.S. had already confirmed it would support the WHO recommendation and published a statement about its rationale for the vote:

“The vote of the United States to remove cannabis and cannabis resin from Schedule IV of the Single Convention while retaining them in Schedule I is consistent with the science demonstrating that while a safe and effective cannabis-derived therapeutic has been developed, cannabis itself continues to pose significant risks to public health and should continue to be controlled under the international drug control conventions. Further, this action has the potential to stimulate global research into the therapeutic potential and public health effects of cannabis, and to attract additional investigators to the field, including those who may have been deterred by the Schedule IV status of cannabis.”  

In MAPS’ announcement of the lawsuit, it points out that “[e]fforts to conduct meaningful research into cannabis medicines have been blocked for decades; the continued obstruction is causing suffering for people with serious conditions,” which indicates the timeliness of this lawsuit in relation to the CND’s recent vote. According to MAPS and the lawsuit, the DEA has failed to process more than thirty outstanding applications to develop cannabis for research purposes for more than four years despite administrative guidance. The press release outlines the nature of the lawsuit as follows:

“Nearly 20 years after Dr. Lyle Craker of the University of Massachusetts – Amherst first applied for a license to develop a consistent, reliable pharmaceutical cannabis product to address the needs of patients with serious illnesses. Despite broad public support for legal, regulated access to medical marijuana, as well as new DEA policy pronouncements and an opinion by the U.S. Department of Justice that the Agency refused to publicly disclose, the DEA has continued to prevent the processing of license applications in violation of the Administrative Procedures Act and contravention of its own administrative guidance. Dr. Craker, supported by the Multidisciplinary Association for Psychedelic Studies (MAPS), has filed a lawsuit in the U.S. District Court in Massachusetts to compel the Drug Enforcement Administration (DEA) to end their delay and process marijuana producer and manufacturer license applications thereby allowing sanctioned scientific research toward a viable medical cannabis pharmaceutical product to proceed.”

House Approves Bill To Enhance Medical Marijuana Research
Photo by CasarsaGuru/Getty Images

Under the Controlled Substances Act (CSA), manufacturers of all Schedule I controlled substances, including marijuana, must be licensed by the DEA. Currently, and since 1968, the only federal license issued to provide cannabis for clinical research purposes belongs to the University of Mississippi and is supervised by the National Institute on Drug Abuse (NIDA).

RELATED: House Approves Bill To Enhance Medical Marijuana Research

According to the lawsuit, and widely discussed opinion throughout the industry, the marijuana provided by the University of Mississippi and NIDA is unfit for clinical research due to “poor quality, unstable supply, and limited variability that in no way emulates the types of cannabis currently available through either state-regulated markets or informal markets where regulated supply is unavailable.”

In addition, this limited, poor quality supply of marijuana is only for permitted use in research and not in commercial sales, meaning it cannot be used in FDA-regulated Phase 3 studies which must be conducted with the exact drug, manufactured under Good Manufacturing Processes, that would be marketed.

RELATED: ICYMI: DEA And Cannabis Research Still Lousy Bedfellows

The goal in compelling the DEA to process these outstanding license applications is to allow for additional research into the potential medical benefits and uses of marijuana – something that in the U.S. has undeniably become an issue with bi-partisan support, yet remains mindbogglingly difficult to achieve through government channels. The results of the November election approving cannabis legalization measures across the board in the U.S., coupled with the CND’s vote to remove medicinal cannabis from Schedule IV, indicates that the time is nigh for the DEA to cooperate in ensuring that medical marijuana research can move forward. Finally.

Alison Malsbury is co-chair of Harris Bricken’s corporate practice group and focuses her practice on health and wellness, in addition to corporate and intellectual property transactions, working primarily with our cannabis, tech and entertainment clients. 

This story was originally published on the Canna Law Blog.

Don't Miss Your Weekly Dose of The Fresh Toast.

Stay informed with exclusive news briefs delivered directly to your inbox every Friday.

We respect your privacy. Unsubscribe anytime.